Combining Compassion with Business Acumen to Make a Positive Difference

US Leadership Team

The ITF Therapeutics team includes experts in all areas of rare disease product development and commercialization who share a passion to make a positive difference for people living with rare diseases.

Matt Trudeau

President, ITF Therapeutics

Scott Baver

Vice President, Head of US Medical Affairs

Dan O'Connell

Vice President, Head of US Sales & Marketing

Caroline Allen

Head of US Patient Advocacy & Communications

Melinda Keegan

Head of US Human Resources

Stephanie Trafton

Head of US Value & Access

Christina Tumminello

Head of US Business Operations

Tony Chambers

Head of US Commercial Effectiveness

Italfarmaco Global Leadership Team

Francesco De Santis

Chairman

Carlos Barallobre

CEO